Evidence map›Paper›PMID 23623790›Full record

ArticleBiochemical pharmacology2013

GABAA receptor modulation by piperine and a non-TRPV1 activating derivative.

Sophia Khom, Barbara Strommer, Angela Schöffmann, Juliane Hintersteiner, Igor Baburin, Thomas Erker, Thomas Schwarz, Christoph Schwarzer, Janine Zaugg, Matthias Hamburger and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Biochemical pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Effect of Black Pepper (Nutrients · 2022
    Article
  5. Review
  6. Remedia Sternutatoria over the Centuries: TRP Mediation.Molecules (Basel, Switzerland) · 2021
    Review
  7. Review
  8. Article
  9. International journal of molecular sciences · 2020
    Article
  10. Article
  11. Review
  12. A distinct structural mechanism underlies TRPV1 activation by piperine.Biochemical and biophysical research communications · 2019
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Sophia KhomDepartment of Pharmacology and Toxicology, University of Vienna, Althanstraße 14, A-1090 Wien, Austria.
Barbara Strommer
Angela Schöffmann
Juliane Hintersteiner
Igor Baburin
Thomas Erker
Thomas Schwarz
Christoph Schwarzer
Janine Zaugg
Matthias Hamburger
Steffen Hering
University of Vienna · ATUniversity of Basel · CHInnsbruck Medical University · AT

Funding

Austrian Science Fund FWF W 1232
6 · The paper itself

Abstract

The action of piperine (the pungent component of pepper) and its derivative SCT-66 ((2E,4E)-5-(1,3-benzodioxol-5-yl))-N,N-diisobutyl-2,4-pentadienamide) on different gamma-aminobutyric acid (GABA) type A (GABA(A)) receptors, transient-receptor-potential-vanilloid-1 (TRPV1) receptors and behavioural effects were investigated. GABA(A) receptor subtypes and TRPV1 receptors were expressed in Xenopus laevis oocytes. Modulation of GABA-induced chloride currents (I(GABA)) by piperine and SCT-66 and activation of TRPV1 was studied using the two-microelectrode-voltage-clamp technique and fast perfusion. Their effects on explorative behaviour, thermoregulation and seizure threshold were analysed in mice. Piperine acted with similar potency on all GABA(A) receptor subtypes (EC₅₀ range: 42.8±7.6 μM (α₂β₂)-59.6±12.3 μM (α₃β₂). I(GABA) modulation by piperine did not require the presence of a γ(2S)-subunit, suggesting a binding site involving only α and β subunits. I(GABA) activation was slightly more efficacious on receptors formed from β(2/3) subunits (maximal I(GABA) stimulation through α₁β₃ receptors: 332±64% and α₁β₂: 271±36% vs. α₁β₁: 171±22%, p<0.05) and α₃-subunits (α₃β₂: 375±51% vs. α₅β₂:136±22%, p<0.05). Replacing the piperidine ring by a N,N-diisobutyl residue (SCT-66) prevents interactions with TRPV1 and simultaneously increases the potency and efficiency of GABA(A) receptor modulation. SCT-66 displayed greater efficacy on GABA(A) receptors than piperine, with different subunit-dependence. Both compounds induced anxiolytic, anticonvulsant effects and reduced locomotor activity; however, SCT-66 induced stronger anxiolysis without decreasing body temperature and without the proconvulsive effects of TRPV1 activation and thus may serve as a scaffold for the development of novel GABA(A) receptor modulators.

Indexed as

Piper nigrumAlkaloidsAnimalsBenzodioxolesGABA ModulatorsMaleMiceMice, Inbred C57BLMotor ActivityPiperidinesPolyunsaturated AlkamidesProtein BindingReceptors, GABA-ATRPV Cation ChannelsAlkaloidsBenzodioxolesGABA ModulatorsPiperidinespiperinePolyunsaturated AlkamidesReceptors, GABA-ATRPV1 protein, mouseTRPV Cation Channels

Identifiers

PMID23623790
PMCPMC3776227
OpenAlexW2019251440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.